UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): April 20, 2015

 

 

 

Dendreon Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

 

 

Delaware   001-35546   22-3203193

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 

601 Union Street, Suite 4900,

Seattle, Washington

   

98101

(Address of Principal Executive Offices)    

(Zip Code)

Registrant’s telephone number, including area code: (206) 256-4545

Not applicable.

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 7.01.  Regulation FD Disclosure.

As previously announced, on November 10, 2014, Dendreon Corporation (the “Company”) and its wholly owned subsidiaries, Dendreon Holdings, LLC, Dendreon Distribution, LLC and Dendreon Manufacturing, LLC (collectively, together with the Company, the “Debtors”) filed voluntary petitions for relief (the “Chapter 11 Cases”) under Chapter 11 of Title 11 of the United States Code (the “Bankruptcy Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”).

On April 20, 2015, the Debtors filed their monthly operating report for the period of March 2015 (the “Monthly Operating Report”) with the Bankruptcy Court. The Monthly Operating Report is attached hereto as Exhibit 99.1.

Cautionary Statement Regarding the Monthly Operating Report

The Company cautions investors and potential investors not to place undue reliance upon the information contained in the Monthly Operating Report, which was not prepared for the purpose of providing the basis for an investment decision relating to any of the securities of the Company. The Monthly Operating Report is limited in scope and has been prepared solely for the purpose of complying with requirements of the Bankruptcy Court. The Monthly Operating Report was not reviewed by independent accountants, is in a format prescribed by applicable bankruptcy laws, and is subject to future adjustment. The financial statements in the Monthly Operating Report are not prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and, therefore, may exclude items required by GAAP, such as certain reclassifications, eliminations, accruals, valuations and disclosures. The Monthly Operating Report also contains information for periods that are shorter or otherwise different from the historical periods required in the Company’s reports pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and such information might not be indicative of the Company’s financial condition or operating results for a period that would be reflected in the Company’s financial statements or in its reports pursuant to the Exchange Act. Information set forth in the Monthly Operating Report should not be viewed as indicative of future results.

Cautionary Statements Regarding the Chapter 11 Cases

The Company’s securityholders are cautioned that trading in the Company’s securities during the pendency of the Chapter 11 Cases will be highly speculative and will pose substantial risks. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery, if any, by holders thereof in the Company’s Chapter 11 Cases. Accordingly, the Company urges extreme caution with respect to existing and future investments in its securities. The Bankruptcy Court has entered an order that places limitations on trading in the Company’s common stock, including options and certain other rights to acquire common stock, and certain instruments convertible into common stock, during the pendency of the bankruptcy proceedings.

The proposed plan of liquidation filed by the Debtors with the Bankruptcy Court on April 16, 2015 contemplates that the holders of the Company’s capital stock will receive no distribution on account of their interests and cancellation of their existing stock. If certain requirements of the Bankruptcy Code are met, a Chapter 11 plan can be confirmed notwithstanding its rejection by the Company’s equity securityholders and notwithstanding the fact that such equity securityholders do not receive or retain any property on account of their equity interests under the plan.

Cautionary Statement Regarding Forward-Looking Statements

Certain information in this Current Report on Form 8-K and Exhibit 99.1 attached hereto (collectively, this “Current Report”) may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Current Report that are not statements of historical fact, including estimates, projections, future trends and the outcome of events that have not yet occurred referenced in this Current Report should be considered forward-looking statements. Words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “may,” “predict,” “will,” “would,” “could,” “should,” “target” and similar expressions are often used to identify forward-looking statements. Actual results or events could differ materially from those indicated in forward-looking statements as a result of risks and uncertainties, including,


among others, the potential adverse impact of the Chapter 11 Cases on the Company’s liquidity or results of operations, changes in the Company’s ability to meet financial obligations during the Chapter 11 process or to maintain contracts that are critical to the Company’s wind-down of its affairs, the outcome or timing of the Chapter 11 process, the effect of the Chapter 11 Cases or the recently completed asset sale transaction with Valeant Pharmaceuticals International, Inc. and Drone Acquisition Sub on the Company’s relationships with third parties, regulatory authorities and employees in connection with the Company’s wind-down of its affairs, proceedings that may be brought by third parties in connection with the Chapter 11 process, the ability of the Company to fund the wind-down of its affairs and the timing or amount of any distributions to the Company’s stakeholders. For a discussion of some of the additional risks and important factors that the Company believes could cause actual results or events to differ from the forward-looking statements that it makes, see the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014. In addition, new risks and uncertainties emerge from time to time, and it is not possible for the Company to predict or assess the impact of every factor that may cause its actual results or events to differ from those contained in any forward-looking statements. Accordingly, you should not place undue reliance on any forward-looking statements contained in this Current Report. Any forward-looking statements speak only as of the date of this Current Report. The Company undertakes no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.

Limitation on Incorporation by Reference

In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 (including Exhibit 99.1) of this Current Report is being furnished for informational purposes only and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as otherwise expressly stated in such filing. The filing of this Current Report will not be deemed an admission as to the materiality of any information required to be disclosed solely by Regulation FD.

Additional Information Regarding the Chapter 11 Cases

Information about the Chapter 11 process, as well as court filings and other documents related to the reorganization proceedings, is available through the Company’s claims agent, Prime Clerk, at https://cases.primeclerk.com/dendreon or 844-794-3479. Information contained on, or that can be accessed through, such web site or the Bankruptcy Court’s web site is not part of this Current Report.

Item 9.01.  Financial Statements and Exhibits.

 (d) Exhibits:

 

99.1 Monthly Operating Report, dated April 20, 2015

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

DENDREON CORPORATION
Date: April 21, 2015 By:  

/s/ Robert L. Crotty

Name: Robert L. Crotty
 Title: President, General Counsel and Secretary


INDEX TO EXHIBITS

 

     Exhibit     
     No.     
     

Description

99.1     Monthly Operating Report, dated April 20, 2015


Exhibit 99.1

 

THE UNITED STATES BANKRUPTCY COURT

FOR THE DISTRICT OF DELAWARE

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  - x
:
In re: :   Chapter 11
:
DENDREON CORPORATION, et al., :   Case No. 14-12515 (LSS)
:

Debtors.1

:   Jointly Administered
:
:
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - x

NOTICE OF FILING OF DEBTORS’ MONTHLY OPERATING REPORT

FOR THE PERIOD OF MARCH 2015

PLEASE TAKE NOTICE that the above-captioned debtors and debtors in possession (collectively, the “Debtors”) have filed with the United States Bankruptcy Court for the District of Delaware the Debtors’ Monthly Operating Report for the Period of March 2015,

 

 

 

 

1  The Debtors and the last four digits of their respective taxpayer identification numbers are as follows: Dendreon Corporation (3193), Dendreon Holdings, LLC (8047), Dendreon Distribution, LLC (8598) and Dendreon Manufacturing, LLC (7123). The address of the Debtors’ corporate headquarters is 601 Union Street, Suite 4900, Seattle, Washington 98101.

 

Docket No. 615

Date Filed: 4/20/15


attached hereto as Exhibit A (the “Monthly Operating Report”).

 

Dated: Wilmington, Delaware
April 20, 2015
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP

/s/ Sarah E. Pierce

Anthony W. Clark (I.D. No. 2051)
Sarah E. Pierce (I.D. No. 4648)
One Rodney Square
P.O. Box 636
Wilmington, Delaware 19899-0636
Telephone: (302) 651-3000
Fax: (302) 651-3001
- and -
Kenneth S. Ziman
Raquelle L. Kaye
Four Times Square
New York, New York 10036-6522
Telephone: (212) 735-3000
Fax: (212) 735-2000
- and -
Felicia Gerber Perlman
155 N. Wacker Drive
Chicago, Illinois 60606-1720
Telephone: (312) 407-0700
Fax: (312) 407-0411
Counsel for Debtors and Debtors in Possession

 

2


EXHIBIT A

MONTHLY OPERATING REPORT


UNITED STATES BANKRUPTCY COURT

                     DISTRICT OF DELAWARE                    

 

In re     DENDREON CORPORATION, et. al                    

Case No.     14-12515_(LSS)                    
Reporting Period:   March 2015                    

MONTHLY OPERATING REPORT

File with Court and submit copy to United States Trustee within 20 days after end of month.

Submit copy of report to any official committee appointed in the case.

 

   REQUIRED DOCUMENTS       Form No.         Document  
Attached
 Explanation 
Attached
Affidavit/Supplement 
Attached 

Schedule of Cash Receipts and Disbursements

MOR-1 X    

Bank Reconciliation (or copies of debtor’s bank reconciliations)

MOR-1a X    

Schedule of Professional Fees Paid

MOR-1b X    

Copies of bank statements

    X  

Cash disbursements journals

    X  

Statement of Operations

MOR-2 X    

Balance Sheet

MOR-3 X    

Status of Postpetition Taxes

MOR-4   X  

Copies of IRS Form 6123 or payment receipt

       

Copies of tax returns filed during reporting period

       

Summary of Unpaid Postpetition Debts

MOR-5 X    

Listing of aged accounts payable

MOR-5 X    

Accounts Receivable Reconciliation and Aging

MOR-6   X  

Debtor Questionnaire

MOR-7 X    

 

I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the attached documents are true and correct to the best of my knowledge and belief.

 

 

 

Signature of Debtor Date

 

            

 

Signature of Joint Debtor Date

/s/ Gregory R. Cox

April 20, 2015                       
Signature of Authorized Individual* Date
Gregory R. Cox                                       

Chief Financial Officer

Printed Name of Authorized Individual Title of Authorized Individual
*Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor is a partnership; a manager or member if debtor is a limited liability company.

 

MOR

(04/07)


 NOTES

 

Notes to the MOR:

This Monthly Operating Report (“MOR”) has been prepared solely for the purpose of complying with the monthly reporting requirements applicable in the Bankruptcy Case and is in a format acceptable to the U.S. Trustee. The financial information contained herein is limited in scope and covers a limited time period. Moreover, such information is preliminary and unaudited, and is not prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States. Accordingly, this MOR should not be used for investment purposes.

The financial statements presented in MOR-2 and MOR-3 are prepared on a consolidated company basis for the Debtors and non-debtor affiliates.

 

Page 2 of 13


 1. SCHEDULE OF CASH RECEIPTS AND DISBURSEMENTS

 

 ($ 000s)

 

For the period 2/28/15 - 3/27/151

       Consolidated                  Dendreon
    Corporation    
    Dendreon
    Holdings    
     Dendreon
    Distribution    
    Dendreon
    Manufacturing    
 
 

Beginning Cash Balance2

    $ 460,666             $ 460,445       $ -        $ 221       $ -   
 

Total Cash Receipts

     28,085              9,401        -         18,684        -   
 

Total Cash Disbursements3

     (30,084           (11,180     -         (18,905     -   
 

Intercompany Transfer From / (To) Other Debtors

     -              -        -         -        -   
 

Intercompany Transfer From / (To) Non-Debtors

     -              -        -         -        -   
 
  

 

 

         

 

 

   

 

 

    

 

 

   

 

 

 
 

Net Cash Flow

   $ (2,000         $ (1,779   $ -       $ (221   $ -   
 
  

 

 

         

 

 

   

 

 

    

 

 

   

 

 

 
 

Ending Cash Balance2

   $ 458,667            $ 458,667      $ -       $ -      $ -   

 

Notes:

 

1. 3/27/15 represents last day of Debtors’ March weekly cash forecast

2. Excludes restricted cash accounts

3. Cash Disbursements include payroll that was disbursed by Dendreon Corporation through its centralized cash management system for the benefit of subsidiary debtors. Accordingly, disbursement amounts (for the purposes of calculating US Trustee fees) are as follows:

 

Debtor

 

  

      Amounts       

 

    

                                                                                              

Dendreon Corporation

    $               11,070       

 

Dendreon Holdings

  

 

 

 

-     

 

  

  

 

Dendreon Distribution

  

 

 

 

19,005 

 

  

  

 

Dendreon Manufacturing

  

 

 

 

 

  

  
  

 

 

    
  

 

 $

 

30,084 

 

  

  

 

 

Page 3 of 13


 1a. BANK RECONCILIATION (OR COPIES OF DEBTORS’ BANK RECONCILIATIONS)

 

As of 3/31/15

                                   Restricted Cash Accounts    

Bank

  U.S. Bank     U.S. Bank    

Morgan Stanley

Smith Barney

    U.S. Bank1          U.S. Bank  
 

 

 

      

 

 

 
Description           Operating Account             Receipts Account             Investment Account             Payroll Account          Escrow Account  

Bank Balance

  $ 232,750      $ 4,956,228      $ 450,887,199      $ 7,254,422         $ 214,617   

(+) Deposits in Transit

    -        -        -        -           -   

(-) Outstanding Checks

    (59,988     -        -        -           -   

Other

    -        (4,956,228     -        -           -   
 

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Book Balance

  $ 172,762      $ -      $ 450,887,199      $ 7,254,422         $ 214,617   

Notes:

 

1. Account opened during postpetition period

 

Page 4 of 13


 1b. SCHEDULE OF PROFESSIONAL FEES PAID

 

For the period 2/28/15 - 3/27/15

 

Firm

         Payment Date                      Amount              

CENTERVIEW PARTNERS LLC

   3/27/15      200,870.20    

SULLIVAN & CROMWELL, LLP

   3/27/15      154,397.24    

EPIQ BANKRUPTCY SOLUTIONS

   3/27/15      1,761.00    

YOUNG CONAWAY STARGATT & TAYLOR, LLP

   3/27/15      33,007.12    
     

 

 

 

Total

       $ 390,035.56    

 

Page 5 of 13


 

 1c. COPIES OF BANK STATEMENTS

 

The Debtors’ bank statements are voluminous and not included herein, but copies will be provided upon request

 

Page 6 of 13


 

 1d. CASH DISBURSEMENTS JOURNALS

 

The Debtors’ cash disbursement journals are voluminous and not included herein, but copies will be provided upon request

 

Page 7 of 13


2. STATEMENT OF OPERATIONS

 

    
 ($ 000s)                         
                        
 For the period 3/1/15 - 3/31/15      Consolidated1                 

 

Dendreon

    Corporation    

        

    Dendreon    

Holdings

        

Dendreon

    Distribution    

        

Dendreon

  Manufacturing  

 
 

Product Revenue, net

     -             $ -          $ -         $ -          $ -   

Royalty and Other Revenue

     226               226           -           -           -   
  

 

 

          

 

 

      

 

 

      

 

 

      

 

 

 

Total Revenue

   $ 226             $ 226          $ -         $ -          $ -   
 

Operating Expenses:

                          

Cost Of Product Revenue

     7               7           -           -           -   

Research and Development

     0               0           -           -           -   

Selling, General and Administrative

     230               230           -           -           -   

Less: Payroll Expense Included In Categories Above2

     (146            (146        -           -           -   

Payroll Expense2,3

     146               37           -           100           9   

Restructuring

     306               306           -           -           -   
  

 

 

          

 

 

      

 

 

      

 

 

      

 

 

 

Total Operating Expenses

 

   $ 542             $ 433          $ -         $ 100          $ 9   
  

 

 

          

 

 

      

 

 

      

 

 

      

 

 

 

Income / (Loss) from Operations

    $ (316           $ (207       $ -          $ (100       $ (9
 

Other Income / (Expense):

                          

Interest Income

     20               20           -           -           -   

Interest Expense

     -               -           -           -           -   

Other Income / (Expense)

     -               -           -           -           -   

Reorganization Expense

     (6,105            (6,105        -           -           -   
  

 

 

          

 

 

      

 

 

      

 

 

      

 

 

 

Net Income / (Loss)

    $ (6,402           $ (6,292       $ -          $ (100       $ (9

 

 Notes:

1. The Debtors maintain their accounting records and prepare financial statements on a consolidated basis only. This modified presentation reflects cash basis payroll of the subsidiary entities, which is funded by Dendreon Corp.

 

2. The Debtors’ consolidated statement of operations reflects an allocation of payroll expenses among several operating expense categories (i.e., Cost of Product Revenue, R&D and SG&A). For the purpose of presenting payroll by entity without double-counting of such expenses, the cash basis payroll must be deducted before being included separately

 

3. Payroll Expense (noted above) includes payroll, payroll taxes and 401(k). These amounts are funded to ADP via the US Bank Payroll account. For taxation purposes, each legal entity pays separate state employment taxes for the states in which it operates

 

Page 8 of 13


3. BALANCE SHEET

 

 

 ($ 000s)

 

 

 As of 3/31/15

 

 
          Consolidated1      

Current Assets:

 

Cash and Cash Equivalents

   $ 458,787   

Short-Term Investments

    -   

Trade Accounts Receivable

    -   

Inventory

    -   

Prepaid Expenses and Other Current Assets

    380   
 

 

 

 

Total Current Assets

   $ 459,167   

Property and Equipment, net

    -   

Long-Term Investments

    49,500   

Other Assets

    2,623   
 

 

 

 

Total Assets

   $ 511,289   

Current Liabilities:

 

Accounts Payable

   $ 1,864   

Accrued Liabilities

    465   

Accrued Compensation

    2,966   

Restructuring Liability

    -   

Reorganization Liability

    11,075   

Current Portion of Capital Lease Obligations

    -   

Current Portion of Facility Lease Obligations

    -   
 

 

 

 

Total Current Liabilities

   $ 16,371   

Long-Term Liabilities:

 

Other Long-Term Liabilities

    -   

Liabilities Subject to Compromise2,3

    593,745   
 

 

 

 

Total Liabilities

   $ 610,116   

Stockholders’ Equity:

 

Common Stock

    156   

Additional Paid-In Capital

    2,021,701   

Accumulated Other Comprehensive Income

    -   

Accumulated Deficit

    (2,120,683
 

 

 

 

Total Stockholders’ Equity (Deficit)

 

   $

 

(98,827

 

 

 

 

 

 

Total Liabilities and Stockholders’ Equity

   $ 511,289   
 

 Notes:

  

1. The Debtors maintain their accounting records and prepare financial statements on a consolidated basis only

 

2. The Debtors continue to work to determine the proper balance and reporting for Liabilities Subject to Compromise

 

3. Additional adjustment of $50k to correct prior period calculation of accrued interest listed in Liabilities Subject to Compromise

   

   

   

 

Page 9 of 13


 

 4. STATUS OF POSTPETITION TAXES

 

All postpetition taxes were current as of 3/31/15 and paid in the ordinary course by the Debtors

 

Page 10 of 13


 

 5. SUMMARY OF UNPAID POSTPETITION DEBTS

 

As of 3/31/15

       

Days Outstanding

   

Total

 

1 - 30

 

31 - 60

 

61 -  90

 

91 +

Postpetition Accounts Payable

   $        1,864,154      $         1,864,154      $                         -     $                         -     $                         - 

 

Page 11 of 13


 

 6. ACCOUNTS RECEIVABLE RECONCILLIATION & AGEING

 

Pursuant to the sale, accounts receivable are no longer property of the Debtors’ estate

 

Page 12 of 13


7. DEBTOR QUESTIONNAIRE

 

 

       

            Yes            

 

            No            

        1.    

Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below

 

      X
        2.    

Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below

 

      X
        3.    

Have all postpetition tax returns been timely filed? If no, provide an explanation below

 

  X    
        4.    

Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below

 

  X    
        5.     Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3     X

 

Page 13 of 13